Toward an Improved Understanding of HDL Function (R01)
ArchivedNational Institutes of Health
Description
This FOA encourages grant applications that propose to develop, validate, and standardize assays to measure HDL function and biomarkers for HDL function and to identify new pathways and potential HDL targets in the relationship to HDL function. Innovative methods to determine HDL functional properties such as in vivo reverse cholesterol transport (RCT), anti-oxidant, anti-inflammatory, and antithrombotic activities, and biomarkers for HDL function are encouraged. Projects that will explore HDL novel functional pathways and therapeutics related to HDL function are also encouraged.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV
- PostedMar 28, 2012
- ClosesSep 7, 2012
- CFDA93.837
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro